Multibagger Penny Stock Under Rs 25: Company Acquired 46,70,761 Equity Shares in Optimus Oncology Pvt Ltd
The stock gave multibagger returns of 330 per cent in 3 years and a whopping 1,370 per cent in 5 years.
PVP Ventures Limited has acquired 46,70,761 Equity Shares in Optimus Oncology Private Limited by paying the total consideration amount of Rs 54,73,66,481 (Rupees Fifty Four Crores Seventy Three Lakhs Sixty Six Thousand Four Hundred and Eighty One Only). By virtue of acquiring a substantial stake in Optimus Oncology Private Limited, the Company Optimus Oncology Private Limited becomes the subsidiary of PVP Ventures Limited with effect from today, i.e. 05th May 2025.
Established in 2018, Optimus Oncology Pvt Ltd (OOPL) was founded by a team of Radiation Oncologists from Tata Memorial Hospital in Mumbai. OOPL partners with local hospitals to establish Oncology Centres, primarily serving patients in Tier 2 and Tier 3 cities and towns across India. With a current financial year EBITDA exceeding Rs 10 crore, OOPL is projected to reach an EBITDA of Rs 50 crore within the next 5 years, supported by PVP's investment. Currently operating centres in Dhule, Latur, Akola, and Solapur in Maharashtra, OOPL plans to expand within Maharashtra and into Gujarat and Madhya Pradesh, aiming to become a national oncology player.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
PVP Ventures Ltd, armed with a substantial legacy realty asset in Chennai and the strength of its group resources, is strategically venturing into India's burgeoning technology-enabled healthcare services market with a clear vision of long-term shareholder value creation. Demonstrating swift action towards its goal of establishing a technology-led portfolio of healthcare brands, PVP is actively pursuing growth through acquisitions and has already forged development agreements with prominent real estate developers like Brigade Enterprises Ltd and Casagrande Premier Builder Ltd to monetise its existing land holdings. Anticipating cash inflows exceeding Rs 2000 crore over the next six years from these realty developments, PVP is channelling these resources into the global healthcare services sector, positioning itself for significant leadership in the industry.
The stock’s 52-week high is Rs 39.28 per share while its 52-week low is Rs 20.10 per share. The company has a market cap of over Rs 600 crore. The stock gave multibagger returns of 330 per cent in 3 years and a whopping 1,370 per cent in 5 years.
Disclaimer: The article is for informational purposes only and not investment advice.